Shigeru Yasue
Directeur/Bestuurslid bij HuLA immune, Inc.
Profiel
Shigeru Yasue is currently a Director at HuLA immune, Inc. He was previously a Director at TMS Co., Ltd.
Actieve functies van Shigeru Yasue
| Bedrijven | Functie | Begin |
|---|---|---|
HuLA immune, Inc.
 HuLA immune, Inc. Pharmaceuticals: MajorHealth Technology HuLA immune, Inc. is a Japanese company that provides immune cell therapy for cancer treatment. The company is based in Tokyo, Japan. The text in the company's description appears to be a mix of non-English languages, including British English and Japanese. It was founded in 2017 and the CEO is Yasuhiro Shindo. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Shigeru Yasue
| Bedrijven | Functie | Einde |
|---|---|---|
| TMS CO., LTD. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TMS CO., LTD. | Commercial Services |
| Bedrijven in privébezit | 1 |
|---|---|
HuLA immune, Inc.
HuLA immune, Inc. Pharmaceuticals: MajorHealth Technology HuLA immune, Inc. is a Japanese company that provides immune cell therapy for cancer treatment. The company is based in Tokyo, Japan. The text in the company's description appears to be a mix of non-English languages, including British English and Japanese. It was founded in 2017 and the CEO is Yasuhiro Shindo. | Health Technology |
